News & media
CLL Advocates December Newsletter
As you probably noted the interim report of the Pharmac Review Panel was released by Hon Andrew…
CLL Advocates November Newsletter
Neil was the driving force and inspiring leader behind CLL Advocates and gave an enormous amount of…
SARS-CoV-2 IgG Serology Testing
This assay can potentially be used to assess vaccine response and to detect previous infection.
Request for Feedback – October Newsletter
Our monthly newsletter has now been going for a year and a half, and I’d like to hear back from you…
Media release: Where is the Pharmac Review Panel’s Report?
Patient advocacy groups and clinicians are calling out the Pharmac Review Panel for failing to get…
CLLANZ Newsletter September 2021 – Learn the latest international developments in CLL treatments
CLLANZ Newsletter September 2021
Global Leukemia Patient Experience Survey 2021
The CLL Advocates Network is asking for you to contribute to the 2021 Global Leukemia Patient…
‘I am screwed if it comes back’ Experts concerned by Covid’s hidden impact on blood cancer treatments
Around 21,000 Kiwis are living with blood cancer. Symptoms can be difficult to recognisegnise
WATCH – Blood Cancer Patient Forum 2021
The 2021 Blood Cancer Patient Forum. held virtually, is now available to view online.
CLL Horizons 2021 – 5-7 November 2021 – Register Now!
The CLL Horizons Conference is a unique opportunity for patient advocates and patient organization…
Understanding your connection with Clinical Trials 2021
Andrew Schorr has kindly shared this on our CLL Advocates NZ Private Facebook Group which we…
Who will be eligible for a third Covid jab in the UK?
Half a million people will be offered another vaccine shot, with a decision on autumn boosters yet…
An expert hematologist/oncologist highlights
An expert hematologist/oncologist highlights key takeaways for the future management of chronic…
World CLL Day – 1 September
Every 1 September, the global CLL community unites to raise awareness about Chronic Lymphocytic…
Responses to COVID-19 Vaccines Vary in Patients With Hematologic Malignancies
Research has suggested that patients with hematologic malignancies may not mount an effective…
The Medicine Gap
The Medicine Gap is helping to provide a collective voice to the thousands and thousands of New…
Pharmac commits to being more transparent
On 28 July for the first time Pharmac released its ‘Options for investment list’.
As a Cancer Patient, Will I Need an Extra Dose of a COVID-19 Vaccine?
This is the sixth in a multipart series exploring important questions about COVID-19 and its unique…
CLL and Dermatology
More than a quarter of CLL patients experience skin issues. On Thursday, August 12th, at 2 pm PDT/5…
Newsletter #13: Submission to Panel Reviewing Pharmac
Our major activity over the past month has been engaging with the independent Panel set up by the…
Covid-19 Vaccines May Not Produce Sufficient Antibody Response in Transplant Recipients
When clinical trials were conducted to determine the immunogenicity — the ability to elicit an…
CLL Advocates Newsletter Issue 12
Covid-19 and CLL prevention and treatment - an update.
Is there a link between CLL and stomach pain?
People with CLL may experience discomfort, swelling, and pain in the abdomen if their spleen…
CLL Advocates Newsletter Issue 11
Skin infection (cellulitis) and CLL - a cautionary tale
Attempting to target the tumor microenvironment leads the way to an array of potential targetable pathways in the disease..
According to the researchers, attempting to target the tumor microenvironment leads the way to an…
Medical specialist says Pharmac ‘wish list’ is a ‘necessity list’
Health expert discusses Pharmac's funding option list.
CLL Advocates Newsletter Issue 10
Welcome to issue 10 of the CLL Advocates newsletter.